AUTOMATION OF THE COLONY-FORMING CELL ASSAY FOR MEASURING HEMATOPOIETIC PROGENITORS IN CORD BLOOD

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "AUTOMATION OF THE COLONY-FORMING CELL ASSAY FOR MEASURING HEMATOPOIETIC PROGENITORS IN CORD BLOOD"

Transcription

1 AUTOMATION OF THE COLONY-FORMING CELL ASSAY FOR MEASURING HEMATOPOIETIC PROGENITORS IN CORD BLOOD Bert Wognum Oliver Egeler Caren Grande Ning Yuan Steven Woodside Terry Thomas Allen Eaves STEMCELL Technologies Inc. (Vancouver, Canada)

2 HEMATOPOIETIC COLONY FORMING CELL/UNIT (CFC or CFU) ASSAY Applications in Hematopoietic Stem and Progenitor Cell Transplantation: Assessing Frequency and Quality of hematopoietic Progenitors in Cell Products Quality Control of Cell Therapy Laboratory Procedures Potential Use for Graft Selection CFC content of grafts correlates with : Time to neutrophil engraftment Time to platelet engraftment Overall survival Prasad et al., Blood 112: ; Page et al. J., Biology of Blood and Marrow Transplantation (2011), in press.

3 HEMATOPOIETIC CFC-ASSAY 1. Prepare Cells 2. Add cells to semisolid medium 3. Plate and Incubate 14 days in most media Total CFC, BFU-E, CFU-GM, CFU-GEMM 7 days in selected media Total CFC only 4. Count Colonies

4 VARIABILITY OF CFC-ASSAY RESULTS Intra-laboratory Coefficient of Variation: 10-20% (STEMCELLL: in-house data) Inter-laboratory Coefficient of Variation: ~30% (Spellman et al: Cytotherapy Mar 30) Manual Colony Counting is one Source of Variability in the CFC-Assay Goal: Standardize the CFC-assay on Cord Blood and reduce variability by automating colony identification and enumeration

5 AUTOMATION OF COLONY IDENTIFICATION AND SCORING 7-day CFC-assay: Total colonies 14-day CFC-assay: Total, Erythroid and Myeloid colonies

6 AUTOMATED COLONY DETECTION IN 7-DAY CFC-ASSAY

7 AUTOMATED COLONY DETECTION AND CLASSIFICATION IN 14-DAY CFC-ASSAY Erythroid Myeloid

8 MANUAL AND AUTOMATED COUNTS SHOW STRONG CORRELATION 7-DAY CFC-ASSAYS ON CB Regression analysis: y=1.02x R 2 = 0.92 N=294 Bias* = -4.0% Data contributing laboratories: StemCell Technologies n=102 3 NMDP-associated CB Banks n=192 Assays were performed in MethoCult Express * Bias = % average difference between manual and automated counts

9 MANUAL AND AUTOMATED COUNTS SHOW STRONG CORRELATION 14-DAY CFC-ASSAYS ON CB Total CFCs Regression analysis: y=0.98x R 2 = 0.83 N=167 Bias* = -9.0 % Data contributing laboratories: StemCell Technologies n= 62 4 NMDP associated CB Banks: n=105 Assays were performed in MethoCult H4034, H4434 or H4435. * Bias = % average difference between manual and automated counts

10 MANUAL AND AUTOMATED COUNTS SHOW STRONG CORRELATION 14-DAY CFC-ASSAYS ON CB Erythroid Colonies Myeloid Colonies

11 REPRODUCIBILITY OF COLONY COUNTING: which method has lower variability? Coefficient of Variation (CV) of: Manual (microscopic) counts by 3-5 people counting the same cultures 7-day CFC-assay : Overall CV= 11% N=36

12 AUTOMATED COLONY COUNTS ARE MORE REPRODUCIBLE THAN MANUAL COLONY COUNTS Coefficient of Variation (CV) of: Manual (microscopic) counts by 3-5 people counting the same cultures Replicate automated counts of the same cultures imaged repeatedly on 3-5 instruments 7-day CFC-assay : Overall CV= 11% : Overall CV= 5% N=36

13 AUTOMATED COLONY COUNTS ARE MORE REPRODUCIBLE THAN MANUAL COLONY COUNTS Variability of pooled replicate data Manual Automated Total CFC (7 day assay) Total CFC (14 day assay) 11% 5% 12% 5% BFU-E 11% 10% CFU-GM+CFU- GEMM 17% 9%

14 CONCLUSIONS AND FUTURE DIRECTIONS Automated Colony Identification and Counting: 1. Shows good correlation with manual colony counting in 7 day and 14 day CFC-assays on Cord Blood 2. Reduces variability relative to manual colony counting 3. Provides a permanent image record of CFC-assay results 4. Can be modified for specific applications, e.g., CFU-GM enumeration in media without Erythropoietin CFC-assays on other cell sources (BM, MPB, patient samples)

15 ACKNOWLEDGEMENTS STEMCELL Technologies: Research and Development Dept. Instrumentation Group Quality Control Dept. Education & Contract Assay Services Collaborators: Puget Sound Blood Center, Seattle, Washington, USA MD Anderson Cancer Center, Houston, Texas, USA Duke University Medical Center, Durham, North Carolina, USA St. Louis Cord Blood Bank, St. Louis, Missouri, USA Anthony Nolan Trust, Nottingham, UK Vancouver, British Columbia, Canada

16

Automated and Standardized Counting of CFU Assays of Human Hematopoietic Cells

Automated and Standardized Counting of CFU Assays of Human Hematopoietic Cells Automated and Standardized Counting of CFU Assays of Human Hematopoietic Cells 2 Automated and Standardized Colony Counting Table of Contents 4 Standardized Counting of Colony-Forming Unit Assays (CFU)

More information

Automated and Standardized Counting of CFU Assays for Cord Blood Banks

Automated and Standardized Counting of CFU Assays for Cord Blood Banks Automated and Standardized Counting of CFU Assays for Cord Blood Banks 2 Automated and Standardized Colony Counting Table of Contents 4 The Colony-Forming Unit (CFU) Assay for Cord Blood Banks 5 The CFU

More information

Proliferation/Potency Assays: Is there more to CD34 and CFU?

Proliferation/Potency Assays: Is there more to CD34 and CFU? Proliferation/Potency Assays: Is there more to CD34 and CFU? CBMTG 2012 Laboratory Committee Meeting April 11, 2012 Toronto, ON, Canada Leah Marquez-Curtis CBS-Edmonton OUTLINE I. Rationale and Definitions

More information

Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between

Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program ISCT 2012 Disclosures: none The problem:

More information

STEMCELL Quality Control Kits

STEMCELL Quality Control Kits STEMCELL Quality Control Kits i Table of Contents 1.0 Introduction...1 2.0 Thawing Cells, Plating and Colony Enumeration...2 2.1 Supplies and reagents included in the QC kit...2 2.2 Additional reagents

More information

Saving your baby s s cord blood: Is this good insurance?

Saving your baby s s cord blood: Is this good insurance? Saving your baby s s cord blood: Is this good insurance? 32 th SEMINAR ON PERINATAL MEDICINE CONTROVERSIES IN PERINATAL MEDICINE: EVIDENCE FOR CURRENT PRACTICE Sante Fe, New Mexico Mervin C. Yoder, MD

More information

A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences

A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences Cytotherapy (2001) Vol. 3, No. 6, 429 433 A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences JM Alonso III 1, DM Regan 1, CE

More information

Stephen J. Szilvassy, PhD Associate Director, Hematopoietic Products R&D STEMCELL Technologies Inc., Vancouver, Canada WWW.STEMCELL.

Stephen J. Szilvassy, PhD Associate Director, Hematopoietic Products R&D STEMCELL Technologies Inc., Vancouver, Canada WWW.STEMCELL. WHITE PAPER Potency Assays for Measuring the Engraftment Potential of Hematopoietic Stem and Progenitor Cells Stephen J. Szilvassy, PhD Associate Director, Hematopoietic Products R&D STEMCELL Technologies

More information

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us

More information

Neutrophil Recovery: The First Step in Posttransplant Recovery

Neutrophil Recovery: The First Step in Posttransplant Recovery Neutrophil Recovery: The First Step in Posttransplant Recovery is Made in the Bone Stem Cell CFU- GEMM BFU-E Pre-B CFU-E White cells B Lymphocyte T Lymphocyte Neutrophils Red cells No conflicts of interest

More information

Processing & Utilization of Cord Blood for Transplant

Processing & Utilization of Cord Blood for Transplant Processing & Utilization of Cord Blood for Transplant 2010-Jan Jan-15 Nicole L. Prokopishyn, PhD HPC Processing Laboratory Director Calgary Laboratory Services Overview Cord Blood Processing Pre-Freeze

More information

Pl I enary Tr T anslational Medicine April 30, 2015

Pl I enary Tr T anslational Medicine April 30, 2015 Plenary I Translational Medicine April 30, 2015 HBO in Hematopoietic Stem Cell Transplantation: Lessons Learned Omar Aljitawi, MD Hematology/Oncology Hematology and Transplantation (HAT) Laboratory Pathology

More information

Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale

Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale Topics 1- NetCord-FACT: l organizzazione internazionale ed il suo scopo 2- Le norme di qualità sul bancaggio

More information

Skeptical UCB Customer: Experiences of University of Rochester/Strong Memorial Transplant Program with Umbilical Cord Blood Units

Skeptical UCB Customer: Experiences of University of Rochester/Strong Memorial Transplant Program with Umbilical Cord Blood Units Skeptical UCB Customer: Experiences of University of Rochester/Strong Memorial Transplant Program with Umbilical Cord Blood Units Craig Mullen, MD, PhD Chief, Pediatric Hematology/Oncology/HSC Transplantation

More information

Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program

Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program Cord Blood: that other stem cell source Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program CBMTG April 2012 The problem: In order to perform a BMT from one person to another one needs

More information

enix Stem Cell Research Assays

enix Stem Cell Research Assays HemoGenix enix Stem Cell Research Assays Methylcellulose CFU-Assays For Hematopoietic Cell Processing These are reagents and assays that allow the clonal detection in methylcellulose. Designed for hematopoietic

More information

Improved Ex Vivo Expansion of Functional CD34 + Cells Using Stemline II Hematopoietic Stem Cell Expansion Medium

Improved Ex Vivo Expansion of Functional CD34 + Cells Using Stemline II Hematopoietic Stem Cell Expansion Medium Improved Ex Vivo Expansion of Functional CD34 + Cells Using Stemline II Hematopoietic Stem Cell Expansion Medium Daniel W. Allison, 1 Stacy L. Leugers, 1 Barry J. Pronold, 2 Gary Van Zant, 2 Jenny A. Harrington,

More information

Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014

Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014 FACT Accreditation for Cord Blood Banks and Cellular Therapy Nadim Mahmud, MD, PhD Associate Professor of Medicine Division of Hematology/Oncology Director, Hospital Stem Cell Laboratory Blood & Marrow

More information

Cell Recovery Sufficient for Adult Transplantation by Additional Cord Blood Collection From Placenta

Cell Recovery Sufficient for Adult Transplantation by Additional Cord Blood Collection From Placenta Cell Recovery Sufficient for Adult Transplantation by Additional Cord Blood Collection From Placenta N. Tsagias, K. Kouzi-Koliakos, D. Hamidi-Alamdari, V. Karagiannis, E. Kostidou, and G. Koliakos ABSTRACT

More information

Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit. Karen Ballen, MD Massachusetts General Hospital June, 2012

Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit. Karen Ballen, MD Massachusetts General Hospital June, 2012 Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit Karen Ballen, MD Massachusetts General Hospital June, 2012 OUTLINE Cell Dose HLA Typing HLA C and KIR HLA Antibodies ABO and Racial/Ethnic

More information

Die Periphere Blutstammzell- Transplantation

Die Periphere Blutstammzell- Transplantation Die Periphere Blutstammzell- Transplantation Martin Körbling DGHO, Stuttgart, Oktober 2012 Der Ursprung des Begriffs Stammzelle Alexander Maximow 1909 A. Maximow, Fol. Haematol. 8;1909:125-134 St. Petersburg

More information

1 Materials and methods. 1.1 Materials

1 Materials and methods. 1.1 Materials Vol. 44 No. 5 SCIENCE IN CHINA (Series C) October 2001 Expansion of CD34 + cells from human umbilical cord blood by FL and/or TPO gene transfected human marrow stromal cell lines ZHANG Yi (Æ Ê), TANG Peixian

More information

Public Cord Blood Banking at the National Cord Blood Program (NCBP)

Public Cord Blood Banking at the National Cord Blood Program (NCBP) Public Cord Blood Banking at the National Cord Blood Program (NCBP) A. Scaradavou, MD Medical Director, National Cord Blood Program, New York Blood Center Associate Attending, Pediatric BMT Memorial Sloan-Kettering

More information

Umbilical Cord Blood Transplantation

Umbilical Cord Blood Transplantation Umbilical Cord Blood Transplantation V Rocha MD, PhD Hopital Saint Louis, Paris University 7 CIBMTR Milwaukee Umbilical Cord blood transplantation Background History Clinical results in children and adults

More information

Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units

Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units Journal of Translational Medicine This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Detecting

More information

Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation

Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation Bone Marrow Transplantation, (1999) 23, 131 136 1999 Stockton Press All rights reserved 268 3369/99 $12. http://www.stockton-press.co.uk/bmt Optimal timing for processing and cryopreservation of umbilical

More information

Dr. Geoff Cuvelier. Pediatric Oncologist MD FRCPC

Dr. Geoff Cuvelier. Pediatric Oncologist MD FRCPC Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the

More information

Christian CHABANNON. Centre de Thérapie Cellulaire. Département de Biologie du Cancer & Inserm CBT Institut Paoli-Calmettes, Marseille

Christian CHABANNON. Centre de Thérapie Cellulaire. Département de Biologie du Cancer & Inserm CBT Institut Paoli-Calmettes, Marseille Quality controls, new technologies, JACIE requirements Enumeration of HSCs: How do I? session 2015 EBMT Annual Meeting Istanbul, Turkey Saturday, March 21st 2015 Christian CHABANNON Centre de Thérapie

More information

How to enumerate CD34+ cells? What do you need to consider in the process environment?

How to enumerate CD34+ cells? What do you need to consider in the process environment? ENSEIGNEMENT FORMATION & How to enumerate CD34+ cells? What do you need to consider in the process environment? Flow Cytometry and Cell Analysis Workshop ISCT Annual Meeting Technical Sessions #1 23rd

More information

Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants

Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants Lown R.N., 1 Marsh S.G.E., 1 Blake H., 1 Evseeva I., 1 MacKinnon, S., 2 Pagliuca,

More information

Stem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine

Stem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine Stem Cells and Inner Ear Cell Regeneration Stefan Heller Stanford University School of Medicine Embryonic stem cells Induced pluripotent stem cells Somatic stem cells 50 µm Derived from the inner cell

More information

The Diagnosis of Myeloid Neoplasia by Flow Cytometry. Brent L. Wood MD PhD Dept. of Laboratory Medicine University of Washington, Seattle

The Diagnosis of Myeloid Neoplasia by Flow Cytometry. Brent L. Wood MD PhD Dept. of Laboratory Medicine University of Washington, Seattle The Diagnosis of Myeloid Neoplasia by Flow Cytometry Brent L. Wood MD PhD Dept. of Laboratory Medicine University of Washington, Seattle Basic Principles Abnormal population identification Normal Antigens

More information

A New Beginning: Stem Cell Transplant Challenges. Dr. Wendy Lau Director, Transfusion Medicine, The Hospital for Sick Children April 8, 2016

A New Beginning: Stem Cell Transplant Challenges. Dr. Wendy Lau Director, Transfusion Medicine, The Hospital for Sick Children April 8, 2016 A New Beginning: Stem Cell Transplant Challenges Dr. Wendy Lau Director, Transfusion Medicine, The Hospital for Sick Children April 8, 2016 Objectives 1. Outline cellular therapy products and transfusion

More information

Most Patients who Need an Allo Transplant Can Find a Well Matched Donor

Most Patients who Need an Allo Transplant Can Find a Well Matched Donor Most Patients who Need an Allo Transplant Can Find a Well Matched Donor Important Points: Most patients can find a well matched or a very well matched available adult donor in the Be The Match Registry.

More information

Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport

Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport Cytotherapy (2006) Vol. 8, No. 2, 158/165 Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport V Antonenas 1, F Garvin 1, M Webb 1, M Sartor 2,

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

CD34 numeration through the French external quality control: Impact in the implementation of new technical chapters at the European Pharmacopoeia

CD34 numeration through the French external quality control: Impact in the implementation of new technical chapters at the European Pharmacopoeia CD34 numeration through the French external quality control: Impact in the implementation of new technical chapters at the European Pharmacopoeia Panterne Béatrice Cells and Tissues Coordinator Batch release

More information

CORD BLOOD BANKING IN BRAZIL HOSPITAL ISRAELITA ALBERT EINSTEIN S EXPERIENCE

CORD BLOOD BANKING IN BRAZIL HOSPITAL ISRAELITA ALBERT EINSTEIN S EXPERIENCE CORD BLOOD BANKING IN BRAZIL HOSPITAL ISRAELITA ALBERT EINSTEIN S EXPERIENCE JOSÉ MAURO KUTNER, MD MEDICAL DIRECTOR BLOOD BANK Brazil - South America BARCELONA * * SÃO PAULO Brazil - South America Brazil

More information

Rank Name PHS # Medical Officer

Rank Name PHS # Medical Officer Page 1 of 8 Rank Name PHS #, Medical Officer, CV cover sheet, Date PROFESSIONAL QUALIFICATIONS 8/97-7/99 Senior Staff Fellow, National Institutes of Health (NIH), Dept. of Transfusion Medicine 7/1995 Board

More information

LAB 9 SERIAL DILUTION, POUR PLATES, AND ENUMERATION OF BACTERIA

LAB 9 SERIAL DILUTION, POUR PLATES, AND ENUMERATION OF BACTERIA LAB 9 SERIAL DILUTION, POUR PLATES, AND ENUMERATION OF BACTERIA Introduction The number of bacteria in a small sample can be startling; for example, there are approximately 10 7 to 10 10 bacteria in every

More information

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION

More information

Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients

Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant Recipients Filippo Milano, 1 J. Lee Nelson, 1, 2 Colleen Delaney 1,3 1 Clinical Research Division, Fred Hutchinson Cancer Research

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

Hematopoietic Stem and Progenitor Cells

Hematopoietic Stem and Progenitor Cells MINI-REVIEW Hematopoietic Stem and Progenitor Cells Albertus W. Wognum, PhD Principal Scientist Stephen J. Szilvassy, PhD Director, Hematopoietic Products R&D Introduction Mature blood cells have a finite

More information

Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center

Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center (last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical

More information

One of the most important recent developments in cancer treatment has been the ability to harvest stem

One of the most important recent developments in cancer treatment has been the ability to harvest stem BIOTECHNOLOGY A Patient-Friendly Approach to Human Cell Transplantation One of the most important recent developments in cancer treatment has been the ability to harvest stem cells from bone marrow or

More information

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases ! 21%! EUROCORD 6756 cord blood transplantations performed from 1988 to March 2010 in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases * missing center

More information

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7 10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in

More information

Cord Blood Market Trends, circa 2014

Cord Blood Market Trends, circa 2014 GENReports: Market & Tech Analysis Cord Blood Market Trends, circa 2014 > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us Topic Introduction and Scope The focus of this GEN

More information

11/10/2011. History of CBUs. 10-CBA providing access to unlicensed cord blood units. The FDA s involvement. The FDA s involvement, cont.

11/10/2011. History of CBUs. 10-CBA providing access to unlicensed cord blood units. The FDA s involvement. The FDA s involvement, cont. History of CBUs First CBU transplant done in 1988 10-CBA providing access to unlicensed cord blood units Using the NMDP IND to access unlicensed cord blood units Amy Hays, Sr. Clinical Research Specialist,

More information

Comparability of Cord Blood Units

Comparability of Cord Blood Units Comparability of Cord Blood Units John D. McMannis,, Ph.D. Professor of Cancer Medicine Director, Cell Therapy Laboratory Technical Director, UT MDAnderson Cord Blood Bank Liaison Meeting, Bethesda June

More information

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood [Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,

More information

Review Article A Review of Factors Influencing the Banking of Collected Umbilical Cord Blood Units

Review Article A Review of Factors Influencing the Banking of Collected Umbilical Cord Blood Units Stem Cells International Volume 2013, Article ID 463031, 7 pages http://dx.doi.org/10.1155/2013/463031 Review Article A Review of Factors Influencing the Banking of Collected Umbilical Cord Blood Units

More information

The donor search: the best donor or cord blood unit

The donor search: the best donor or cord blood unit The donor search: the best donor or cord blood unit Dr Bronwen Shaw Consultant in haematopoietic cell transplantation Royal Marsden Hospital /Anthony Nolan Overview Where do we find donors/units for transplantation

More information

hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.

hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge. hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.ch Spring water: Manufactured by nature COSTLESS Cord Blood:

More information

Cord Blood: Thawing & Infusion Practical Methods

Cord Blood: Thawing & Infusion Practical Methods Cord Blood: Thawing & Infusion Practical Methods Donna M Regan, MT(ASCP)SBB St. Louis Cord Blood Bank @ SSM Cardinal Glennon Children s s Medical Center Objectives Present variety of product configurations

More information

Fiscal Year 2013 Annual Progress Report on the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory Program

Fiscal Year 2013 Annual Progress Report on the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory Program U.S. Department of Health and Human Services Fiscal Year 2013 Annual Progress Report on the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory Program Executive Summary The

More information

STEM CELL THERAPEUTIC OUTCOMES DATABASE

STEM CELL THERAPEUTIC OUTCOMES DATABASE C W Bill Young Cell Transplantation Program STEM CELL THERAPEUTIC OUTCOMES DATABASE BUS06_1ppt Stem Cell Therapeutic and Research Act of 2005 (PL 109-129) 129) Authorizing law, preceded by efforts to:

More information

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation

More information

Enumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood

Enumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood Application Note Primary Cell Analysis Enumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood Cell Viability Introduction: Bone Marrow, Cord Blood, Stem

More information

ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012

ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 PAGE 1 OF 7 PRINCIPLES FOR A NEW ALGORITHM Once cord blood transplantation (CBT) is

More information

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 COVERAGE: SPECIAL COMMENT ON POLICY REVIEW: Due to the complexity of the Peripheral and Bone Marrow Stem Cell Transplantation

More information

Automated Cord Blood Processing:

Automated Cord Blood Processing: TM Automated Cord Blood Processing: A Follow-up to the Pilar Solves Study Comparing the AXP vs the Sepax Cord Blood Processing Systems CHRISTY KIM, PETRA CRAVENS, MINDY WILKE-DOUGLAS AND MITCHEL SIVILOTTI

More information

Stem Cell Transplantation

Stem Cell Transplantation Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance

More information

DONOR VEIN ASSESSMENT FOR HEMATOPOIETIC PROGENITOR CELL COLLECTION: AN INTERNATIONAL SURVEY BY THE ASFA HPC DONOR SUBCOMMITTEE

DONOR VEIN ASSESSMENT FOR HEMATOPOIETIC PROGENITOR CELL COLLECTION: AN INTERNATIONAL SURVEY BY THE ASFA HPC DONOR SUBCOMMITTEE DONOR VEIN ASSESSMENT FOR HEMATOPOIETIC PROGENITOR CELL COLLECTION: AN INTERNATIONAL SURVEY BY THE ASFA HPC DONOR SUBCOMMITTEE Mandy Flannery O'Leary, M.D., M.P.H. 1,2, Haewon C. Kim, M.D. 3,4, Nancy M.

More information

The Cord Blood Industry and Be The Match

The Cord Blood Industry and Be The Match The Cord Blood Industry and Be The Match Arthur Busse Manager of Business Analytics NMDP: Be The Match Sept. 11, 2015 Be The Match Mission Saving Lives with cellular therapy through science, service and

More information

Pluripotent: Can differentiate into blood cells of all three lineages (erythroid, myeloid, and megakaryoblastic) Express CD 34+ antigen CD34 most

Pluripotent: Can differentiate into blood cells of all three lineages (erythroid, myeloid, and megakaryoblastic) Express CD 34+ antigen CD34 most Shan Yuan, MD May 11, 2011 Pluripotent: Can differentiate into blood cells of all three lineages (erythroid, myeloid, and megakaryoblastic) Express CD 34+ antigen CD34 most likely an adhesion molecule

More information

Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center

Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center Discuss Quality dashboards as auditing and Reporting Methods for Quality Management Provide examples

More information

Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units

Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units Patterson et al. Journal of Translational Medicine (2015) 13:94 DOI 10.1186/s12967-015-0434-z RESEARCH Open Access Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions

More information

Growth characteristics and expansion of human umbilical cord

Growth characteristics and expansion of human umbilical cord Proc. Nati. Acad. Sci. USA Vol. 89, pp. 4109-4113, May 1992 Medical Sciences Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults

More information

Bone Marrow Transplantation for Severe Aplastic Anemia

Bone Marrow Transplantation for Severe Aplastic Anemia Bone Marrow Transplantation for Severe Aplastic Anemia David A. Margolis, MD Children s Hospital of Wisconsin Medical College of Wisconsin Conference Objectives (cut and pasted from AAMDS.ORG) Learn how

More information

Project Lead: Stephen Forman, M.D. PI: Elizabeth Budde, M.D., Ph.D

Project Lead: Stephen Forman, M.D. PI: Elizabeth Budde, M.D., Ph.D Phase I study using T cells expressing a CD123-specific chimeric antigen receptor and truncated EGFR for patients with relapsed or refractory acute myeloid leukemia Project Lead: Stephen Forman, M.D. PI:

More information

A Cure for Sickle Cell Anemia and Thalassemia

A Cure for Sickle Cell Anemia and Thalassemia IV Simpósio Internacional de Hemoglobinopatias A Cure for Sickle Cell Anemia and Thalassemia Bertram Lubin, MD and Mark Walters, MD 4 September 2007 Topics to be covered Cord blood: Importance and biology

More information

Causes of Anemia in Patients with Heart Failure. Adriaan Voors, MD, PhD, Cardiologist Professor of Cardiology, UMC Groningen, Netherlands

Causes of Anemia in Patients with Heart Failure. Adriaan Voors, MD, PhD, Cardiologist Professor of Cardiology, UMC Groningen, Netherlands Causes of Anemia in Patients with Heart Failure Adriaan Voors, MD, PhD, Cardiologist Professor of Cardiology, UMC Groningen, Netherlands Background Anemia is common in patients with CHF Prevalence 15 55%

More information

ASSEMBLY, No. 2591 STATE OF NEW JERSEY. 212th LEGISLATURE INTRODUCED FEBRUARY 23, 2006

ASSEMBLY, No. 2591 STATE OF NEW JERSEY. 212th LEGISLATURE INTRODUCED FEBRUARY 23, 2006 ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Assemblywoman CHARLOTTE VANDERVALK District (Bergen) SYNOPSIS Requires hospitals to provide information to pregnant

More information

Stem cells possess 2 main characteristics: Sources of pluripotent stem cells: -Long-term self renewal. -The inner cell mass of the blastocyst.

Stem cells possess 2 main characteristics: Sources of pluripotent stem cells: -Long-term self renewal. -The inner cell mass of the blastocyst. Stem cells possess 2 main characteristics: -Long-term self renewal. - They give rise to all types of differentiate cells. Sources of pluripotent stem cells: -The inner cell mass of the blastocyst. - Fetal

More information

UMBILICAL CORD BLOOD, STEM CELL BANKING

UMBILICAL CORD BLOOD, STEM CELL BANKING UMBILICAL CORD BLOOD, STEM CELL BANKING Dr.Sharad Jain MD Blood Transfusion officer, & I/C Transfusion Medicine NSCB Medical College. Jabalpur.MP. Introduction: Every parent during childbirth DREAMS the

More information

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science,

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Lancaster University, UK Today Exploring Perceptions of 'Quality'

More information

Disclosure. Gene Therapy. Transfer of genes into cells Expression of transferred genes

Disclosure. Gene Therapy. Transfer of genes into cells Expression of transferred genes Disclosure Equity interest in Genetix Pharm. Inc. Exclusive license of retroviral cell lines from Columbia No direct participation in MDR clinical trials Columbia U. annual reporting FDA Gene Therapy Transfer

More information

Cord Blood Re-imagined The use of cord blood stem cells for clinical applications and medical innovations

Cord Blood Re-imagined The use of cord blood stem cells for clinical applications and medical innovations GE Healthcare Proceedings of the Symposium Cord Blood Re-imagined The use of cord blood stem cells for clinical applications and medical innovations 12 th Annual Meeting of the International Society for

More information

Hematopoietic Stem Cell Transplantation (HSCT) Overview

Hematopoietic Stem Cell Transplantation (HSCT) Overview Hematopoietic Stem Cell Transplantation (HSCT) Overview Willis H Navarro, MD Medical Director, Transplant Services, NMDP Associate Clinical Professor, UCSF The Leukemia & Lymphoma Society May 20, 2010

More information

My Sister s s Keeper. Science Background Talk

My Sister s s Keeper. Science Background Talk My Sister s s Keeper Science Background Talk Outline Acute promyelocytic leukemia (APL) APL Treatment Savior Siblings In vitro fertilization (IVF) Pre-implantation Genetic Diagnosis (PGD) Risks of donating

More information

Equine Stem Cells. Sources, Processing, Expansion, Storage and Shipping

Equine Stem Cells. Sources, Processing, Expansion, Storage and Shipping Equine Stem Cells Sources, Processing, Expansion, Storage and Shipping Sean Owens, DVM, Diplomate ACVP Medical Director, UC Davis Veterinary Regenerative Medicine Laboratory What is a Stem Cell and What

More information

Design, Operation and Management of GTP/GMP Cell Engineering Facilities

Design, Operation and Management of GTP/GMP Cell Engineering Facilities Design, Operation and Management of GTP/GMP Cell Engineering Facilities Scott R. Burger, MD Advanced Cell & Gene Therapy BFDA 2007 International Symposium on Regulation of Human Cell and Tissue- Based

More information

Hematology 101. Plasma White cells. Red Cells. Red cells. newly released. marrow

Hematology 101. Plasma White cells. Red Cells. Red cells. newly released. marrow Hematocrits Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,

More information

Economics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015

Economics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015 Economics of Cord Blood Banking Michael Boo NMDP Be The Match September 11, 2015 Historical Use UCB Use Data 2 NMDP Historical Transplants by Product 7,000 6,500 6,000 5,500 5,000 4,500 4,000 3,500 3,000

More information

HOUSE BILL REPORT HB 2805

HOUSE BILL REPORT HB 2805 HOUSE BILL REPORT HB 2805 Title: An act relating to umbilical cord blood. As Reported by House Committee On: Health Care & Wellness Appropriations Brief Description: Regarding the collection of umbilical

More information

A Gap Analysis of Research in Apheresis Knowledge Gained from Systematic Review of Clinicaltrials.gov

A Gap Analysis of Research in Apheresis Knowledge Gained from Systematic Review of Clinicaltrials.gov A Gap Analysis of Research in Apheresis Knowledge Gained from Systematic Review of Clinicaltrials.gov Pruthul Patel, Keck School of Medicine of the University of Southern California, Los Angeles, CA Laura

More information

Biological Therapies for Cancer

Biological Therapies for Cancer Biological Therapies for Cancer Key Points Biological therapies use the body's immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Biological therapies

More information

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research infoaging guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research WHAT ARE STEM CELLS? Stem cells are cells that, in cell cultures

More information

Sponsors: Agenda. 2013 BioArchive Users Meeting. Liège, Belgium 23-24 May 2013

Sponsors: Agenda. 2013 BioArchive Users Meeting. Liège, Belgium 23-24 May 2013 2013 BioArchive Users Meeting Liège, Belgium 23-24 May 2013 Agenda Wednesday 22 May 1730 Arrival Ramada Plaza Hotel Liège Quai Saint-Léonard 36 4000 Liège Belgium 0032 (0)4 228 81 73 Thursday 23 May 0800

More information

Prostaglandin E2 Enhances Human Cord Blood Stem. Cell Xenotransplants and Shows Long-Term Safety. in Preclinical Nonhuman Primate Transplant Models

Prostaglandin E2 Enhances Human Cord Blood Stem. Cell Xenotransplants and Shows Long-Term Safety. in Preclinical Nonhuman Primate Transplant Models Cell Stem Cell, Volume 8 Supplemental Information Prostaglandin E2 Enhances Human Cord Blood Stem Cell Xenotransplants and Shows Long-Term Safety in Preclinical Nonhuman Primate Transplant Models Wolfram

More information

Changes to UK NEQAS Leucocyte Immunophenotyping Chimerism Performance Monitoring Systems From April 2014. Uncontrolled Copy

Changes to UK NEQAS Leucocyte Immunophenotyping Chimerism Performance Monitoring Systems From April 2014. Uncontrolled Copy Changes to UK NEQAS Leucocyte Immunophenotyping Chimerism Performance Monitoring Systems From April 2014 Contents 1. The need for change 2. Current systems 3. Proposed z-score system 4. Comparison of z-score

More information

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose Pr Eliane Gluckman, MD, FRCP, Hospital Saint Louis, University Paris- Diderot, France Should Haplo-identical transplantation be preferred to cord blood in patients without a matched donor? Disclosure of

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll

More information

Human Long-Term Culture-Initiating Cell (LTC-IC) Assays

Human Long-Term Culture-Initiating Cell (LTC-IC) Assays i Human Long-Term Culture-Initiating Cell (LTC-IC) Assays TOLL FREE PHONE 1 800 667 0322 PHONE +1 604 877 0713 VERSION 3.1.0 INFO@STEMCELL.COM TECHSUPPORT@STEMCELL.COM FOR GLOBAL CONTACT DETAILS VISIT

More information

GRANIX (tbo-filgrastim)

GRANIX (tbo-filgrastim) RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil

More information

Cord Blood: Research Progress and Future Promise

Cord Blood: Research Progress and Future Promise Cord Blood: Research Progress and Future Promise By Al Staropoli, AABB Contributing Writer Sue Fister found out she had leukemia when she was 50 years old. Doctors suggested a bone marrow transplant as

More information

Recommendations to Transplant Centres Performing Cord Blood Transplants. Why Choosing the Right Thaw Method Could Save a Patient s Life

Recommendations to Transplant Centres Performing Cord Blood Transplants. Why Choosing the Right Thaw Method Could Save a Patient s Life Recommendations to Transplant Centres Performing Cord Blood Transplants Vicki Antonenas Why Choosing the Right Thaw Method Could Save a Patient s Life Lynn O Donnell (USA) 1 The process of receiving, testing

More information